Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Beta-lapachone: Natural occurrence, physicochemical properties, biological activities, toxicity and synthesis
Camila Luiz Gomes, Victor de Albuquerque Wanderley Sales, Camila Gomes de Melo, et al.
Phytochemistry (2021) Vol. 186, pp. 112713-112713
Closed Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Exploring the potential use of pristine and metal-encapsulated B36N36 fullerenes in delivery of β-lapachone anticancer drug: DFT approach
Aref Gholami, Ehsan Shakerzadeh, Ernesto Chigo Anota
Polyhedron (2023) Vol. 232, pp. 116295-116295
Closed Access | Times Cited: 42
Increasing the polarity of β-lapachone does not affect its binding capacity with bovine plasma protein
Otávio Augusto Chaves, Rui J. S. Loureiro, Carlos Serpa, et al.
International Journal of Biological Macromolecules (2024) Vol. 263, pp. 130279-130279
Closed Access | Times Cited: 20
β-Lapachone induces ferroptosis of colorectal cancer cells via NCOA4-mediated ferritinophagy by activating JNK pathway
Lei Zhao, Hui Miao, Mingqi Quan, et al.
Chemico-Biological Interactions (2024) Vol. 389, pp. 110866-110866
Closed Access | Times Cited: 11
An azo bond primary cleavage and C–C bond secondary cleavage-based polymeric β-lapachone prodrug for selective anti-cancer therapy
Weidong Zhao, Mengfei Zheng, Hongyu Chu, et al.
Science China Materials (2025)
Closed Access | Times Cited: 1
Bioactivity of Chitosan-Based Particles Loaded with Plant-Derived Extracts for Biomedical Applications: Emphasis on Antimicrobial Fiber-Based Systems
Joana C. Antunes, Joana Domingues, Catarina S. Miranda, et al.
Marine Drugs (2021) Vol. 19, Iss. 7, pp. 359-359
Open Access | Times Cited: 46
Engineered Biomimetic Copper Sulfide Nanozyme Mediates “Don’t Eat Me” Signaling for Photothermal and Chemodynamic Precision Therapies of Breast Cancer
Zhu Zhan, Weiqiong Zeng, Junzhao Liu, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 20, pp. 24071-24083
Closed Access | Times Cited: 21
A ferroptosis-reinforced nanocatalyst enhances chemodynamic therapy through dual H2O2 production and oxidative stress amplification
X. L. Zhu, Tianyu Wang, Hao‐Ran Jia, et al.
Journal of Controlled Release (2024) Vol. 367, pp. 892-904
Closed Access | Times Cited: 7
Drug discovery inspired by bioactive small molecules from nature
Seyun Kim, Seol-Wa Lim, Jiyeon Choi
Animal Cells and Systems (2022) Vol. 26, Iss. 6, pp. 254-265
Open Access | Times Cited: 25
Tailored Beta‐Lapachone Nanomedicines for Cancer‐Specific Therapy
Yaru Li, Meiyu Feng, Tao Guo, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 20
Closed Access | Times Cited: 16
Neurotrophic Natural Products
Yoshiyasu Fukuyama, Miwa Kubo, Kenichi Harada
Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products (2024), pp. 1-473
Closed Access | Times Cited: 5
Navigating the redox landscape: reactive oxygen species in regulation of cell cycle
Viktoria Mackova, Martina Raudenská, Hana Polanská, et al.
Redox Report (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
Promises of phytochemical based nano drug delivery systems in the management of cancer
Parveen Kumar, Nishant Yadav, Benu Chaudhary, et al.
Chemico-Biological Interactions (2021) Vol. 351, pp. 109745-109745
Closed Access | Times Cited: 29
Redox ticklers and beyond: Naphthoquinone repository in the spotlight against inflammation and associated maladies
Neha Kapoor, Pankaj Kandwal, Gaurav Sharma, et al.
Pharmacological Research (2021) Vol. 174, pp. 105968-105968
Closed Access | Times Cited: 29
Evaluation of β-lapachone-methyl-β-cyclodextrin inclusion complex prepared by spray drying and its application against different developmental stages of Schistosoma mansoni in murine model
Risoleta Nogueira Soares, Eulália Azevedo Ximenes, Sidcley Bernardino Araújo, et al.
Chemico-Biological Interactions (2023) Vol. 373, pp. 110374-110374
Closed Access | Times Cited: 11
Selective activity of Tabebuia avellanedae against Giardia duodenalis infecting organoid-derived human gastrointestinal epithelia
Giulia Rigamonti, Fabrizia Veronesi, Elisabetta Chiaradia, et al.
International Journal for Parasitology Drugs and Drug Resistance (2025) Vol. 27, pp. 100583-100583
Open Access
β-lapachone suppresses carcinogenesis of cervical cancer via interaction with AKT1
Pan Du, Yue Li, Anna Han, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
The Antioxidant and Anti-Diabetic Chemical Compounds in Rhinacanthus nasutus (L.) Kurz Leaf Extract Were Determined Using UHPLC-MS/MS QTOF
Candra Irawan, Berna Elya, Muhammad Hanafi, et al.
Research Journal of Pharmacy and Technology (2025), pp. 495-501
Closed Access
Probing the influence of defects and Si-doping in graphene sheet as an efficacious carrier for drug delivery system in gas and aqua phases - Combined DFT and classical MD simulation
Deepak Arumugam, Mohanapriya Subramani, Ravichandran Durai, et al.
Journal of Physics and Chemistry of Solids (2023) Vol. 181, pp. 111562-111562
Closed Access | Times Cited: 10
Droserone and dioncoquinone B, and related naphthoquinones as potent antiausterity agents against human PANC-1 pancreatic cancer cells
Juthamart Maneenet, Nasir Tajuddeen, Hung Hong Nguyen, et al.
Results in Chemistry (2024) Vol. 7, pp. 101352-101352
Open Access | Times Cited: 3
Telomerase Inhibition in the Treatment of Leukemia: A Comprehensive Review
Elżbieta Bartoszewska, Klaudia Molik, Marta Woźniak, et al.
Antioxidants (2024) Vol. 13, Iss. 4, pp. 427-427
Open Access | Times Cited: 3
Stimuli-Responsive Prodrugs with Self-Immolative Linker for Improved Cancer Therapy
Xu Wenting, Ang Jia, Zhixian Lei, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116928-116928
Closed Access | Times Cited: 3
Identification of Antimotilins, Novel Inhibitors of Helicobacter pylori Flagellar Motility That Inhibit Stomach Colonization in a Mouse Model
Sebastian Suerbaum, Nina Coombs, Lubna Patel, et al.
mBio (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 14
β-lapachone: A Promising Anticancer Agent with a Unique NQO1 Specific Apoptosis in Pancreatic Cancer
Muhammad Imran Qadir, Muhammad Shahid Iqbal, Rimsha Khan
Current Cancer Drug Targets (2022) Vol. 22, Iss. 7, pp. 537-540
Closed Access | Times Cited: 11
Evaluation of doxorubicin and β‐lapachone analogs as anticancer agents, a biological and computational study
Itzel Mercado‐Sánchez, Julio López, Rogelio Chávez‐Rocha, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 1
Closed Access | Times Cited: 2
β-lapachone-mediated WST1 Reduction as Indicator for the Cytosolic Redox Metabolism of Cultured Primary Astrocytes
Patrick Watermann, Ralf Dringen
Neurochemical Research (2023) Vol. 48, Iss. 7, pp. 2148-2160
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top